Resistance of Streptococcus pneumoniae to deformylase inhibitors is due to mutations in defB.

Abstract:

:Resistance to peptide deformylase inhibitors in Escherichia coli or Staphylococcus aureus is due to inactivation of transformylase activity. Knockout experiments in Streptococcus pneumoniae R6x indicate that the transformylase (fmt) and deformylase (defB) genes are essential and that a def paralog (defA) is not. Actinonin-resistant mutants of S. pneumoniae ATCC 49619 harbor mutations in defB but not in fmt. Reintroduction of the mutated defB gene into wild-type S. pneumoniae R6x recreates the resistance phenotype. The altered enzyme displays decreased sensitivity to actinonin.

authors

Margolis P,Hackbarth C,Lopez S,Maniar M,Wang W,Yuan Z,White R,Trias J

doi

10.1128/aac.45.9.2432-2435.2001

subject

Has Abstract

pub_date

2001-09-01 00:00:00

pages

2432-5

issue

9

eissn

0066-4804

issn

1098-6596

journal_volume

45

pub_type

杂志文章
  • Identification of a key lysine residue in heat shock protein 90 required for azole and echinocandin resistance in Aspergillus fumigatus.

    abstract::Heat shock protein 90 (Hsp90) is an essential chaperone involved in the fungal stress response that can be harnessed as a novel antifungal target for the treatment of invasive aspergillosis. We previously showed that genetic repression of Hsp90 reduced Aspergillus fumigatus virulence and potentiated the effect of the ...

    journal_title:Antimicrobial agents and chemotherapy

    pub_type: 杂志文章

    doi:10.1128/AAC.02286-13

    authors: Lamoth F,Juvvadi PR,Soderblom EJ,Moseley MA,Asfaw YG,Steinbach WJ

    更新日期:2014-01-01 00:00:00

  • Linezolid and vancomycin, alone and in combination with rifampin, compared with moxifloxacin against a multidrug-resistant and a vancomycin-tolerant Streptococcus pneumoniae strain in an in vitro pharmacodynamic model.

    abstract::Potential alternatives, including linezolid, adjunctive rifampin, and moxifloxacin, were evaluated against vancomycin-tolerant (P9802-020) and vancomycin-susceptible clinical isolates of Streptococcus pneumoniae in an in vitro pharmacodynamic model. Vancomycin exhibited maximal killing of 2-log(10) CFU/ml against P980...

    journal_title:Antimicrobial agents and chemotherapy

    pub_type: 杂志文章

    doi:10.1128/aac.47.6.1984-1987.2003

    authors: Cha R,Rybak MJ

    更新日期:2003-06-01 00:00:00

  • Scintillation proximity assay for inhibitors of Escherichia coli MurG and, optionally, MraY.

    abstract::MurG and MraY, essential enzymes involved in the synthesis of bacterial peptidoglycan, are difficult to assay because the substrates are lipidic and hard to prepare in large quantities. Based on the use of Escherichia coli membranes lacking PBP1b, we report a high-throughput method to measure the activity of MurG and,...

    journal_title:Antimicrobial agents and chemotherapy

    pub_type: 杂志文章

    doi:10.1128/AAC.49.4.1410-1418.2005

    authors: Ravishankar S,Kumar VP,Chandrakala B,Jha RK,Solapure SM,de Sousa SM

    更新日期:2005-04-01 00:00:00

  • Pyruvate decarboxylase, the target for omeprazole in metronidazole-resistant and iron-restricted Tritrichomonas foetus.

    abstract::The substituted benzimidazole omeprazole, used for the treatment of human peptic ulcer disease, inhibits the growth of the metronidazole-resistant bovine pathogen Tritrichomonas foetus in vitro (MIC at which the growth of parasite cultures is inhibited by 50%, 22 microg/ml [63 microM]). The antitrichomonad activity ap...

    journal_title:Antimicrobial agents and chemotherapy

    pub_type: 杂志文章

    doi:10.1128/AAC.48.6.2185-2189.2004

    authors: Sutak R,Tachezy J,Kulda J,Hrdý I

    更新日期:2004-06-01 00:00:00

  • Transfer of embB codon 306 mutations into clinical Mycobacterium tuberculosis strains alters susceptibility to ethambutol, isoniazid, and rifampin.

    abstract::Implicated as a major mechanism of ethambutol (EMB) resistance in clinical studies of Mycobacterium tuberculosis, mutations in codon 306 of the embB gene (embB306) have also been detected in EMB-susceptible clinical isolates. Other studies have found strong associations between embB306 mutations and multidrug resistan...

    journal_title:Antimicrobial agents and chemotherapy

    pub_type: 杂志文章

    doi:10.1128/AAC.01486-07

    authors: Safi H,Sayers B,Hazbón MH,Alland D

    更新日期:2008-06-01 00:00:00

  • Reduced susceptibilities of Shigella sonnei strains isolated from patients with dysentery to fluoroquinolones.

    abstract::Seven clinical isolates of Shigella sonnei with reduced susceptibilities to fluoroquinolones (sparfloxacin, ciprofloxacin, and ofloxacin) were obtained. The MICs of fluoroquinolones against these S. sonnei strains were 16 to 32 times higher than those obtained against typical strains that are highly susceptible to the...

    journal_title:Antimicrobial agents and chemotherapy

    pub_type: 杂志文章

    doi:10.1128/aac.37.11.2486

    authors: Horiuchi S,Inagaki Y,Yamamoto N,Okamura N,Imagawa Y,Nakaya R

    更新日期:1993-11-01 00:00:00

  • Effect of 2'-nor-cyclic GMP against guinea pig cytomegalovirus infection.

    abstract::Cyclic phosphate derivative of DHPG, 2'-nor-cGMP [9-[(2-hydroxy-1,3,2-dioxaphosphorinan-5-yl)oxymethyl]-guani ne phosphate-oxide] was evaluated for activity against guinea pig cytomegalovirus (GPCMV) infection in cultured guinea pig embryo cells and in guinea pigs. By virus yield reduction and plaque reduction assays,...

    journal_title:Antimicrobial agents and chemotherapy

    pub_type: 杂志文章

    doi:10.1128/aac.33.9.1563

    authors: Yang ZH,Lucia HL,Tolman RL,Colonno RJ,Hsiung GD

    更新日期:1989-09-01 00:00:00

  • Candida in the Respiratory Tract Potentially Triggers Galactomannan Positivity in Nonhematological Patients.

    abstract::BAL fluid samples from critically ill patients shared a rate of 29% false-positive galactomannan results. We aimed to determine whether Candida species abundance in BAL fluid causes galactomannan (GM) positivity. A total of 89 Candida culture-positive BAL fluid samples from patients without suspicion of invasive asper...

    journal_title:Antimicrobial agents and chemotherapy

    pub_type: 杂志文章

    doi:10.1128/AAC.00138-19

    authors: Aigner M,Wanner M,Kreidl P,Lass-Flörl C,Lackner M

    更新日期:2019-05-24 00:00:00

  • Extension of Pharmacokinetic/Pharmacodynamic Time-Kill Studies To Include Lipopolysaccharide/Endotoxin Release from Escherichia coli Exposed to Cefuroxime.

    abstract::The release of inflammatory bacterial products, such as lipopolysaccharide (LPS)/endotoxin, may be increased upon the administration of antibiotics. An improved quantitative understanding of endotoxin release and its relation to antibiotic exposure and bacterial growth/killing may be gained by an integrated analysis o...

    journal_title:Antimicrobial agents and chemotherapy

    pub_type: 杂志文章

    doi:10.1128/AAC.02070-19

    authors: Thorsted A,Tano E,Kaivonen K,Sjölin J,Friberg LE,Nielsen EI

    更新日期:2020-03-24 00:00:00

  • Ribosomal alterations contribute to bacterial resistance against the dipeptide antibiotic TAN 1057.

    abstract::TAN 1057-resistant Staphylococcus aureus and Escherichia coli strains were selected to elucidate the mechanism of resistance and the mode of action of this dipeptide antibiotic. Cell-free translation with isolated ribosomes and S150 fractions from sensitive and resistant S. aureus strains demonstrated that alterations...

    journal_title:Antimicrobial agents and chemotherapy

    pub_type: 杂志文章

    doi:10.1128/aac.48.2.619-622.2004

    authors: Limburg E,Gahlmann R,Kroll HP,Beyer D

    更新日期:2004-02-01 00:00:00

  • Lysostaphin-coated catheters eradicate Staphylococccus aureus challenge and block surface colonization.

    abstract::Lysostaphin is an endopeptidase that kills Staphylococcus aureus, a predominant organism in catheter-related infections. Lysostaphin-coated catheters prevented catheter colonization by several strains of S. aureus, and activity was maintained for at least 4 days. Prophylactic use of lysostaphin in catheters may help p...

    journal_title:Antimicrobial agents and chemotherapy

    pub_type: 杂志文章

    doi:10.1128/AAC.48.7.2704-2707.2004

    authors: Shah A,Mond J,Walsh S

    更新日期:2004-07-01 00:00:00

  • Treatment of experimental herpesvirus infections with phosphonoformate and some comparisons with phosphonoacetate.

    abstract::Phosphonoformate (PF) at a concentration of 5 to 10 mug/ml inhibited the growth of type 1 strains of herpes simplex virus (HSV) in tissue culture, whereas 20 to 30 mug/ml was required for inhibition of type 2 strains and about 50 mug/ml was required for murine cytomegalovirus. In mice inoculated intraperitoneally or i...

    journal_title:Antimicrobial agents and chemotherapy

    pub_type: 杂志文章

    doi:10.1128/aac.14.6.817

    authors: Kern ER,Glasgow LA,Overall JC Jr,Reno JM,Boezi JA

    更新日期:1978-12-01 00:00:00

  • Design of a small-molecule entry inhibitor with activity against primary measles virus strains.

    abstract::The incidence of measles virus (MV) infection has been significantly reduced in many nations through extensive vaccination; however, the virus still causes significant morbidity and mortality in developing countries. Measles outbreaks also occur in some developed countries that have failed to maintain high vaccine cov...

    journal_title:Antimicrobial agents and chemotherapy

    pub_type: 杂志文章

    doi:10.1128/AAC.49.9.3755-3761.2005

    authors: Plemper RK,Doyle J,Sun A,Prussia A,Cheng LT,Rota PA,Liotta DC,Snyder JP,Compans RW

    更新日期:2005-09-01 00:00:00

  • Comparison of fortimicins with other aminoglycosides and effects on bacterial ribosome and protein synthesis.

    abstract::Fortimicins are bicyclic aminoglycoside antibiotics that contain a fortamine moiety instead of the deoxystreptamine found in other aminoglysides. Fortimicin A had a bactericidal effect on Escherichia coli and Staphylococcus epidermidis and was found to inhibit protein synthesis in vivo. In vitro, fortimicin A inhibite...

    journal_title:Antimicrobial agents and chemotherapy

    pub_type: 杂志文章

    doi:10.1128/aac.26.6.857

    authors: Moreau N,Jaxel C,Le Goffic F

    更新日期:1984-12-01 00:00:00

  • Inhibition of bacteriophage lambda, T1, and T7 development by R plasmids of the H incompatibility group.

    abstract::R plasmids from chloramphenicol-resistant salmonella from Ontario are shown to belong to the H(2) incompatibility subgroup and to mediate a broad-spectrum, phage inhibition function. ...

    journal_title:Antimicrobial agents and chemotherapy

    pub_type: 杂志文章

    doi:10.1128/aac.10.4.762

    authors: Taylor DE,Grant RB

    更新日期:1976-10-01 00:00:00

  • Mercury inactivates transcription and the generalized transcription factor TFB in the archaeon Sulfolobus solfataricus.

    abstract::Mercury has a long history as an antimicrobial agent effective against eukaryotic and prokaryotic organisms. Despite its prolonged use, the basis for mercury toxicity in prokaryotes is not well understood. Archaea, like bacteria, are prokaryotes but they use a simplified version of the eukaryotic transcription apparat...

    journal_title:Antimicrobial agents and chemotherapy

    pub_type: 杂志文章

    doi:10.1128/AAC.48.6.1993-1999.2004

    authors: Dixit V,Bini E,Drozda M,Blum P

    更新日期:2004-06-01 00:00:00

  • Antisense oligonucleotide inhibition of hepatitis C virus (HCV) gene expression in livers of mice infected with an HCV-vaccinia virus recombinant.

    abstract::Hepatitis C virus (HCV) is the major cause of non-A, non-B hepatitis worldwide. Current treatments are not curative for most infected individuals, and there is an urgent need for both novel therapeutic agents and small-animal models which can be used to evaluate candidate drugs. A small-animal model of HCV gene expres...

    journal_title:Antimicrobial agents and chemotherapy

    pub_type: 杂志文章

    doi:10.1128/AAC.43.2.347

    authors: Zhang H,Hanecak R,Brown-Driver V,Azad R,Conklin B,Fox MC,Anderson KP

    更新日期:1999-02-01 00:00:00

  • N-acylated derivatives of sulfamethoxazole and sulfafurazole inhibit intracellular growth of Chlamydia trachomatis.

    abstract::Antibacterial compounds with novel modes of action are needed for management of bacterial infections. Here we describe a high-content screen of 9,800 compounds identifying acylated sulfonamides as novel growth inhibitors of the sexually transmitted pathogen Chlamydia trachomatis. The effect was bactericidal and distin...

    journal_title:Antimicrobial agents and chemotherapy

    pub_type: 杂志文章

    doi:10.1128/AAC.02015-13

    authors: Marwaha S,Uvell H,Salin O,Lindgren AE,Silver J,Elofsson M,Gylfe A

    更新日期:2014-05-01 00:00:00

  • Penicillin-binding proteins in a Staphylococcus aureus strain resistant to specific beta-lactam antibiotics.

    abstract::The penicillin-binding proteins (PBPs) of a clinical isolate of Staphylococcus aureus specifically resistant to oral cephalosporins were compared with those of a susceptible strain. In the resistant strain, PBP3 (75,000 molecular weight) was missing or had substantially (greater than 100-fold) reduced affinity for pen...

    journal_title:Antimicrobial agents and chemotherapy

    pub_type: 杂志文章

    doi:10.1128/aac.22.1.172

    authors: Georgopapadakou NH,Smith SA,Bonner DP

    更新日期:1982-07-01 00:00:00

  • Inhaled nitric oxide treatment of patients with pulmonary tuberculosis evidenced by positive sputum smears.

    abstract::Endogenous nitric oxide (NO) has antimycobacterial properties. We tested the hypothesis that exogenous (inhaled) NO can be safely delivered and can accelerate airway disinfection for pulmonary tuberculosis patients treated with standard therapy. Exogenous NO administered at 80 ppm for 72 h can be safely delivered but ...

    journal_title:Antimicrobial agents and chemotherapy

    pub_type: 杂志文章

    doi:10.1128/AAC.49.3.1209-1212.2005

    authors: Long R,Jones R,Talbot J,Mayers I,Barrie J,Hoskinson M,Light B

    更新日期:2005-03-01 00:00:00

  • Efficacy of pyrvinium pamoate against Cryptosporidium parvum infection in vitro and in a neonatal mouse model.

    abstract::No effective approved drug therapy exists for Cryptosporidium infection of immunocompromised patients. Here we investigated the nonabsorbed anthelmintic drug pyrvinium pamoate for inhibition of the growth of the intestinal protozoan parasite Cryptosporidium parvum. The concentration of pyrvinium that effected 50% grow...

    journal_title:Antimicrobial agents and chemotherapy

    pub_type: 杂志文章

    doi:10.1128/AAC.00207-08

    authors: Downey AS,Chong CR,Graczyk TK,Sullivan DJ

    更新日期:2008-09-01 00:00:00

  • Activity of cefazolin against dense populations of enterobacteria.

    abstract::The in vitro activity of cefazolin was assessed by continuous turbidimetric monitoring of cultures of gram-negative bacilli and the results were compared with those previously obtained with other beta-lactam agents using the same strains and methods. Cefazolin was found to induce rapid lysis of ampicillin-susceptible ...

    journal_title:Antimicrobial agents and chemotherapy

    pub_type: 杂志文章

    doi:10.1128/aac.7.2.191

    authors: Greenwood D,Chan-Teoh CH,O'Grady F

    更新日期:1975-02-01 00:00:00

  • Interpretive standards for disk susceptibility tests with Sch 21420 and amikacin.

    abstract::Disk susceptibility tests with two structurally related aminoglycosides (amikacin and Sch 21420) were evaluated. Tests with 10- and 30-micrograms amikacin disks confirmed previous recommendations for interpretive zone standards; 30-micrograms disks are preferred. Tests with 10-, 20-, and 30-micrograms Sch 21420 disks ...

    journal_title:Antimicrobial agents and chemotherapy

    pub_type: 杂志文章

    doi:10.1128/aac.18.4.616

    authors: Barry AL,Thornsberry C,Jones RN,Gerlach EH

    更新日期:1980-10-01 00:00:00

  • Differential Antimicrobial Susceptibilities of Granulicatella adiacens and Abiotrophia defectiva.

    abstract::MICs of 25 Abiotrophia defectiva and 109 Granulicatella adiacens isolates were determined by broth microdilution. Using CLSI breakpoints, the susceptibilities of A. defectiva and G. adiacens isolates were, respectively, 24% and 34% to penicillin, 92% and 22% to ceftriaxone, 48% and 3% to cefepime, 72% and 87% to merop...

    journal_title:Antimicrobial agents and chemotherapy

    pub_type: 杂志文章

    doi:10.1128/AAC.00485-16

    authors: Mushtaq A,Greenwood-Quaintance KE,Cole NC,Kohner PC,Ihde SM,Strand GJ,Harper LW,Virk A,Patel R

    更新日期:2016-07-22 00:00:00

  • Efficacy and safety of pharmacokinetically enhanced amoxicillin-clavulanate at 2,000/125 milligrams twice daily for 5 days versus amoxicillin-clavulanate at 875/125 milligrams twice daily for 7 days in the treatment of acute exacerbations of chronic bronc

    abstract::This randomized, controlled trial was designed to show that a short, 5-day course of pharmacokinetically enhanced amoxicillin-clavulanate at 2,000/125 mg (Augmentin XR) is as effective clinically as a longer, 7-day course of conventional amoxicillin-clavulanate at 875/125 mg (both given twice daily) in the treatment o...

    journal_title:Antimicrobial agents and chemotherapy

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1128/AAC.49.1.153-160.2005

    authors: Sethi S,Breton J,Wynne B

    更新日期:2005-01-01 00:00:00

  • Field evaluation of a novel colorimetric method--double-site enzyme-linked lactate dehydrogenase immunodetection assay--to determine drug susceptibilities of Plasmodium falciparum clinical isolates from northwestern Thailand.

    abstract::A double-site enzyme-linked lactate dehydrogenase enzyme immunodetection assay was tested against field isolates of Plasmodium falciparum for assessing in vitro drug susceptibilities to a wide range of antimalarial drugs. Its sensitivity allowed the use of parasite densities as low as 200 parasites/microl of blood. Be...

    journal_title:Antimicrobial agents and chemotherapy

    pub_type: 杂志文章

    doi:10.1128/aac.48.4.1426-1429.2004

    authors: Brockman A,Singlam S,Phiaphun L,Looareesuwan S,White NJ,Nosten F

    更新日期:2004-04-01 00:00:00

  • In vitro and in vivo antibacterial activities of K-4619, a new semisynthetic aminoglycoside.

    abstract::The antibacterial activities of K-4619 (3-de-O-methylsporaricin A sulfate) were compared with those of sporaricin A, amikacin, dibekacin, and gentamicin. K-4619 exhibited a high order of activity against gram-positive and gram-negative bacteria, including Pseudomonas aeruginosa. Its activity against Providencia specie...

    journal_title:Antimicrobial agents and chemotherapy

    pub_type: 杂志文章

    doi:10.1128/aac.26.2.187

    authors: Saino Y,Hattori Y,Koshi T,Kobayashi F,Oda T,Mitsuhashi S

    更新日期:1984-08-01 00:00:00

  • Antimicrobial susceptibilities of clinical isolates of HACEK organisms.

    abstract::The "HACEK" organisms are a group of fastidious Gram-negative bacteria that cause a variety of infections, including infective endocarditis. Antimicrobial susceptibility testing is not universally available, and therapy for these infections is often empirical. We report the antimicrobial susceptibilities of 70 clinica...

    journal_title:Antimicrobial agents and chemotherapy

    pub_type: 杂志文章

    doi:10.1128/AAC.00111-13

    authors: Coburn B,Toye B,Rawte P,Jamieson FB,Farrell DJ,Patel SN

    更新日期:2013-04-01 00:00:00

  • Liquid chromatographic assay of ketoconazole.

    abstract::A reverse-phase, high-pressure liquid chromatographic method for the rapid and quantitative determination of ketoconazole has been developed. Drug levels from 0.5 to 10 microgram/ml can be determined in either yeast nitrogen base medium or human serum by using an octadecylsilane column. A retention time of 4.9 +/- 0.1...

    journal_title:Antimicrobial agents and chemotherapy

    pub_type: 杂志文章

    doi:10.1128/aac.19.1.110

    authors: Andrews FA,Peterson LR,Beggs WH,Crankshaw D,Sarosi GA

    更新日期:1981-01-01 00:00:00

  • Characterization of vancomycin resistance in Enterococcus faecium and Enterococcus faecalis.

    abstract::Vancomycin resistance in Enterococcus faecium 180, a clinical isolate from England, was studied. Resistance to vancomycin was transferable by conjugation to other enterococci. Expression of resistance was inducible and coincided with the appearance of a new membrane protein. ...

    journal_title:Antimicrobial agents and chemotherapy

    pub_type: 杂志文章

    doi:10.1128/aac.33.7.1121

    authors: Nicas TI,Wu CY,Hobbs JN Jr,Preston DA,Allen NE

    更新日期:1989-07-01 00:00:00